A group of angel investors operates with a fund model with an average check size of USD $100K – $500K. The firm will both lead deals and will follow-on as well as syndicate with other angel groups. The majority of deals fall within the Seed-Series A range. The group only invests in U.S.-based C-Corps.
The firm is typically sector-agnostic in terms of technology and life science. Some members are more interested in early-stage Seed deals while others are looking for technologies that have been adequately de-risked.
The firm is looking for privately-held, technology-based companies with experienced management teams that can demonstrate strong execution skills, potential for market dominance, high growth, and a sustainable competitive advantage.
For deals where the firm would be acting as a co-investor, it is required that the round have a strong lead investor – i.e. one that actively negotiated the term sheet, represents a sizeable portion of the round, is taking an active role in the company (usually has a board seat) and has completed an internal due diligence effort and is willing to share the results of their due diligence effort with the firm members.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment